About Fulgent genetics
Fulgent Genetics: Revolutionizing Clinical Diagnostic Genetic Sequencing
Fulgent Genetics is a leading provider of genetic testing and sequencing services that has been accredited by the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA). The company was founded in 2011 with a mission to make genetic testing more accessible, affordable, and accurate for patients worldwide. Since then, Fulgent has become a trusted partner for healthcare providers, researchers, and pharmaceutical companies seeking reliable genetic data to inform clinical decision-making.
At Fulgent Genetics, we believe that genetics holds the key to unlocking personalized medicine. By analyzing an individual's DNA sequence, we can identify inherited mutations or variations that may increase their risk of developing certain diseases or conditions. This information can help doctors diagnose diseases earlier, develop targeted therapies based on a patient's unique genetic makeup, and even prevent some illnesses from occurring altogether.
Our state-of-the-art laboratory facilities are equipped with cutting-edge technology that allows us to perform high-throughput sequencing at scale. We use next-generation sequencing (NGS) platforms such as Illumina HiSeq X Ten and NovaSeq 6000 to generate vast amounts of genomic data quickly and accurately. Our bioinformatics team then analyzes this data using proprietary algorithms to identify clinically relevant variants with high accuracy.
Fulgent offers a wide range of genetic tests across multiple specialties including cardiology, neurology, oncology, reproductive health, pediatrics among others. Our tests include carrier screening for inherited disorders such as cystic fibrosis or sickle cell anemia; hereditary cancer panels which test for mutations associated with increased risk of developing certain cancers; pharmacogenomics testing which helps predict how individuals will respond to certain medications based on their genetics; preimplantation genetic diagnosis (PGD) which screens embryos before implantation during IVF cycles among others.
One area where Fulgent Genetics stands out is our ability to customize our tests according to specific needs or research questions posed by clients. We work closely with healthcare providers or researchers who have unique requirements in terms of gene coverage depth or variant classification criteria among other factors so as they get exactly what they need from our services.
Another advantage we offer is our fast turnaround time - most results are available within two weeks after sample receipt at our lab facility located in Temple City California USA . This quick turnaround time ensures timely clinical decision-making while minimizing patient anxiety waiting for results.
In addition to providing diagnostic services directly through healthcare providers' offices , Fulgent also partners with pharmaceutical companies conducting clinical trials requiring genomic profiling . Our expertise in NGS-based diagnostics makes us an ideal partner for these studies since we can provide comprehensive genomic profiling solutions tailored specifically towards each study's objectives .
At Fulgent Genetics , quality assurance is paramount . We adhere strictly not only CAP/CLIA guidelines but also ISO 15189 standards ensuring highest quality standards are met throughout all stages from sample collection through analysis reporting .
In conclusion , if you're looking for reliable , accurate , fast-turnaround-time diagnostic sequencing services look no further than Fulgent Genetics . With over ten years experience providing NGS-based diagnostics across multiple specialties coupled with state-of-the-art laboratory facilities equipped latest technology platforms backed up by highly skilled bioinformatics team ; you can trust us deliver highest quality results every time!